IL36G and obesity disorder: The increased expression of IL36G in VAT of patients with obesity and CC may reflect a dysregulated immune response, exacerbating both local and systemic inflammation and contributing to the inflammatory microenvironment surrounding tumours, potentially promoting carcinogenesis.